Balasa Dinverno & Foltz’s Cerence CRNC Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q1
Sell
-6,371
Closed -$488K 349
2021
Q4
$488K Sell
6,371
-577
-8% -$50.9K 0.03% 205
2021
Q3
$668K Sell
6,948
-103
-1% -$11.2K 0.05% 163
2021
Q2
$752K Sell
7,051
-329
-4% -$32.4K 0.05% 145
2021
Q1
$661K Sell
7,380
-278
-4% -$30.6K 0.05% 150
2020
Q4
$769K Sell
7,658
-1,247
-14% -$93K 0.06% 126
2020
Q3
$435K Hold
8,905
0.04% 165
2020
Q2
$364K Sell
8,905
-9,753
-52% -$280K 0.04% 156
2020
Q1
$287K Buy
+18,658
New +$392K 0.04% 189

Other funds holding CRNC

Balasa Dinverno & Foltz's CRNC Position: Q1 2022 in Review

Balasa Dinverno & Foltz sold out of Cerence (CRNC) in Q1 2022, closing a stake of 6,371 shares — an estimated $488K sold.

Balasa Dinverno & Foltz first reported a position in CRNC in Q1 2020 and held it in 8 quarters. The position peaked at $769K in Q4 2020. 286 funds tracked by Wall St. Rank hold CRNC as of Q1 2022.

  • Balasa Dinverno & Foltz reported no remaining Cerence position as of Q1 2022 after selling out during the quarter.
  • Balasa Dinverno & Foltz sold 6,371 Cerence shares in Q1 2022, an estimated $488K.
  • Balasa Dinverno & Foltz first reported a position in Cerence in Q1 2020 and held it in 8 quarters.
  • Balasa Dinverno & Foltz's Cerence position peaked at $769K in Q4 2020.
  • 286 funds tracked by Wall St. Rank held Cerence as of Q1 2022.

Based on Balasa Dinverno & Foltz's 13F filing for Q1 2022, filed 25 Apr 2022.